Amy M. Ford

Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319

Christopher C. Frye, Tamer Coskun, J. M. Beals, 2013, PloS one.

FGF-21 as a novel metabolic regulator.

J. Gromada, G. Sandusky, F. Mehrbod, 2005, The Journal of clinical investigation.

Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.

C. Fraser, J. Hale, Deshan Li, 2005, Endocrinology.

Cecal ligation and puncture with total parenteral nutrition: a clinically relevant model of the metabolic, hormonal, and inflammatory dysfunction associated with critical illness.

R. L. Grubbs, Yun-Fei Chen, J. Jakubowski, 2004, The Journal of surgical research.